A Review of Islet of Langerhans Degeneration in Rodent Models of Type 2 Diabetes

Toxicologic Pathology

Volumn 36, Issue 4, 2008, Pages 529-551

  Nugent, David A ^a,b   Smith, David M ^c   Jones, Huw B ^a  

^a Pathology Department   (United Kingdom)

^b UNIVERSITY OF BRADFORD   (United Kingdom)

^c ASTRAZENECA   (United Kingdom)

Author keywords

Diabetes; islet of Langerhans degeneration; pathology; rodent models; cell

Indexed keywords

AMYLIN; GLUCOSE; PROINSULIN;

AMYLOIDOSIS; CELL DEGENERATION; CELL FUNCTION; CYTOTOXICITY; DISEASE COURSE; DISEASE MODEL; GOTO KAKIZAKI RAT; HISTOPATHOLOGY; HUMAN; INSULIN RESISTANCE; KNOCKOUT MOUSE; LIPID DIET; NON INSULIN DEPENDENT DIABETES MELLITUS; NONHUMAN; OTSUKA LONG EVANS TOKUSHIMA FATTY RAT; PANCREAS ISLET; PANCREAS ISLET BETA CELL; PANCREAS ISLET CELL; PANCREAS RESECTION; PATHOPHYSIOLOGY; PRIORITY JOURNAL; PSAMMOMYS OBESUS; REVIEW; STREPTOZOCIN DIABETES; TRANSGENIC MOUSE; ZUCKER DIABETIC FATTY RAT; ZUCKER RAT;

ANIMALS; DIABETES MELLITUS, EXPERIMENTAL; DIABETES MELLITUS, TYPE 2; GENE EXPRESSION; HUMANS; INSULIN RESISTANCE; ISLETS OF LANGERHANS; RODENTIA; STREPTOZOCIN; TRANSGENES;

ANIMALIA; RODENTIA;

EID: 49749087978     PISSN: 01926233     EISSN: None     Source Type: Journal    
DOI: 10.1177/0192623308318209     Document Type: Review

References (192)

1. Abdel-Halim SM Guenifi A Efendic S Östenson CG Both somatostatin and insulin responses to glucose are impaired in the perfused pancreas of the spontaneously non insulin-dependent diabetic GK (Goto-Kakizaki) rat Acta Physiol Scand 1993 148 219 26
2. Abdul-Ghani MA Tripathy D DeFronzo RA Contributions of β-cell dysfunction and insulin resistance to the pathogenesis of impaired glucose tolerance and impaired fasting glucose Diabetes Care 2006 5 1130 9
3. Ahlgren U Jonsson J Jonsson L Simu K Edlund H β-Cell-specific inactivation of the mouse Ipf1/Pdx1 gene results in loss of the β-cell phenotype and maturity onset diabetes Genes Dev 1998 12 1763 8
4. Alacron C Leahy JL Schuppin GT Rhodes CJ Increased secretory demand rather than a defect in the proinsulin conversion mechanism causes hyperproinsulinaemia in a glucose-infusion rat model of non-insulin-dependent diabetes mellitus J Clin Invest 1995 95 1032 9
5. Alemzadeh R Tushaus KM Modulation of adipoinsular axis in prediabetic Zucker diabetic fatty rats by diazoxide Endocrinology 2004 154 5476 84
6. Alvarez C Bailbe D Picarel-Blanchot F Bertin E Pascual-Leone AM Portha B Effect of early dietary restriction on insulin action and secretion in the GK rat, a spontaneous model of NIDDM Am J Physiol Endocrinol Metab 2000 278 E1097 103
7. Andrikopoulos S Verchere CB Terauchi Y Kadowaski T Kahn SE Beta-cell glucokinase deficiency and hyperglycaemia are associated with reduced islet amyloid deposition in a mouse model of type 2 diabetes Diabetes 2000 46 2056 62
8. Atef N Portha B Penicaud L Changes in islet blood flow in rats with NIDDM Diabetologia 1994 37 677 80
9. Bady I Marty N Dallaporta M Emery M Gyger J Tarussio D Foretz M Thorens B Evidence from glut2-null mice that glucose is a critical physiological regulator of feeding Diabetes 2006 55 988 95
10. Barceló A Rajpathak S Incidence and prevalence of diabetes mellitus in the Americas Am J Public Health 2001 10 300 8
11. Barker DJP Fetal origins of coronary heart disease BMJ 1995 311 171 4
12. Barnett M Collier GR Collier FMcL Zimmet P O’Dea K A cross-sectional and short-term longitudinal characterisation of NIDDM in Psammomys obesus Diabetologia 1994 37 671 6
13. Bar-On H Ben-Sasson R Ziv E Arar N Shafrir E Irreversibility of nutritionally induced NIDDM in Psammomys obesus is related to beta-cell apoptosis Pancreas 1999 18 259 65
14. Bernal-Mizrachi E Fatrai S Johnson JD Ohsugi M Otani K Han Z Polonsky KS Permutt MA Defective insulin secretion and increased susceptibility to experimental diabetes are induced by reduced Akt activity in pancreatic islet beta cells J Clin Invest 2004 114 928 36
15. Bisbis S Bailbe D Tormo MA Picarel-Blanchot F Derouet M Simon J Portha B Insulin resistance in the GK rat: decreased receptor number but normal kinase activity in liver Am J Physiol 1993 265 E807 13
16. Bonner-Weir S Kahn CR Weir GC King GL Jacobson AM Moses AC Smith RJ Islets of Langerhans: morphology and postnatal growth Joslin’s Diabetes Mellitus 2005 14 Philadelphia Lippincott Williams & Wilkins 41 52
17. Brissova M Blaha M Spear C Nicholson W Radhika A Shiota M Charron MJ Wright CVE Powers AC Reduced PDX-1 expression impairs islet response to insulin resistance and worsens glucose homeostasis Am J Physiol Endocrinol Metab 2004 288 E707 14
18. Buckingham RE Al-Barazanji KA Toseland CDN Slaughter M Connor SC West A Bond B Turner NC Clapham JC Peroxisome proliferator-activated receptor-γ agonist, rosiglitazone, protects against nephropathy and pancreatic islet abnormalities in Zucker fatty rats Diabetes 1998 47 1326 34
19. Butler AE Jang J Gurlo T Carty MD Soeller WC Butler PC Diabetes due to a progressive defect in β-cell mass in rats transgenic for human islet amyloid polypeptide (HIP rat) Diabetes 2004 53 1509 16
20. Cardinal JW Allan DJ Cameron DP Poly(ADP-ribose) polymerase activation determines strain sensitivity to streptozotocin-induced β cell death in inbred mice J Mol Endocrinol 1999 22 65 70
21. Carlsson PO Jansson L Östenson CG Kallskog O Islet capillary blood pressure increase mediated by hyperglycaemia in NIDDM GK rats Diabetes 1997 46 947 52
22. Charreau EH Calvo JC Tesone M Valle LBS Baraño JL Insulin regulation of leydig cell luteinizing hormone receptors J Biol Chem 1978 253 2504 6
23. Chan CB Wright GM Wadowska DW MacPhail RM Ireland WP Sulston KW Ultrastructural and secretory heterogeneity of fa/fa (Zucker) rat islets Mol Cell Endocrinol 1998 136 119 29
24. Chirieac DV Heidi LC Cianci J Sparks JD Sparks CE Altered triglyceride-rich lipoprotein production in Zucker diabetic fatty rats Am J Physiol Endocrinol Metabol 2004 1 E42 9
25. Clark A Bown E King T Vanhegan RI Turner RC Islet changes induced by hyperglycaemia in rats. Effects of insulin or chlorpropamide therapy Diabetes 1982 3 319 25
26. Clark A Cooper GJ Lewis CE Morris JF Willis AC Reid KB Turner RC Islet amyloid formed from diabetes-associated peptide may be pathogenic in type-2 diabetes Lancet 1987 330 231 4
27. Clark A Saad MF Nezzer T Uren C Knowler WC Bennett PH Turner RC Islet amyloid polypeptide in diabetic and non-diabetic Pima Indians Diabetologia 1990 33 285 9
28. Clark A de Koning EJP Hattersley AT Hansen BC Yajnik CS Poulton J Pancreatic pathology in non-insulin dependent diabetes (NIDDM) Diabetes Res Clin Pract 1995 28 S39 47
29. Clark A Charge SB Badman MK de Koning EJ Islet amyloid in type 2 (non-insulin dependent) diabetes Acta Pathol Microbiol Immunol Scand 1996 104 12 8
30. Clarke PM Levy JC Burnett M Turner RC Hales CN Immunoradiometric assay of insulin, proinsulin and 32–33 split proinsulin and radioassay of insulin in diet-treated type 2 (non-insulin dependent) diabetic subjects Diabetologia 1992 35 469 74
31. Coresttis JP Sparks JD Peterson RG Smith RL Sparks CE Effect of dietary fat on the development of non-insulin dependent diabetes mellitus in obese Zucker diabetic fatty male and female rats Atherosclerosis 1999 148 231 41
32. D’Alessio DA Verchere CB Kahn SE Hoagland V Baskin DG Palmiter RD Ensinck JW Pancreatic expression and secretion of human islet amyloid polypeptide in a transgenic mouse Diabetes 1994 43 1457 61
33. Danda RS Habiba NM Rincon-Choles H Bhadaria BK Barnes JL Abboud HE Pergola PE Kidney involvement in a non-genetic rat model of type 2 diabetes Kidney Int 2005 68 256 71
34. Degen AA Energy requirements of the fat sand rat (Psammomys obesus) when consuming the saltbush, Atriplex halimus: a review J Basic Clin Physiol Pharmacol 1993 4 13 28
35. de Koning EJ Bodkin NL Hansen BC Clark A Diabetes mellitus in Macaca mulatto monkeys is characterised by islet amyloidosis and reduction in beta-cell population Diabetologia 1993 36 378 84
36. de Koning EJ Fleming KA Gray DW Clark A High prevalence of pancreatic islet amyloid in patients with end-stage renal failure on dialysis treatment J Pathol 1995 175 253 8
37. Drake AJ Smith A Betts PR Crowne EC Shield JPH Type 2 diabetes in obese white children Arch Dis Child 2002 86 207 8
38. Engelgau MM Narayan KMV Saaddine JB Vinicar F Addressing the burden of diabetes in the 21st century: better care and primary prevention J Am Soc Nephrol 2003 14 S88 91
39. Erdely A Freshour G Maddox D Olson J Samsell L Baylis C Renal disease in rats with type 2 diabetes is associated with decreased renal nitric oxide production Diabetologia 2004 47 1672 6
40. Fabregat ME Novials A Giroix MH Sener A Gomis R Malaisse WJ Pancreatic islet mitochondrial glycerolphosphate dehydrogenase deficiency in two animal models of non-insulin-dependent diabetes mellitus Biochem Biophys Res Commun 1996 220 1020 3
41. Farilla L Hui H Bertolotto C Kang E Bulotta A DiMario U Perfetti R Glucagon-like peptide-1 promotes islet cell growth and inhibits apoptosis in Zucker diabetic rats Endocrinology 2002 143 4397 408
42. Ferrannini E Insulin resistance versus insulin deficiency in non-insulin-dependent diabetes mellitus: problems and prospects Endocr Rev 1998 19 477 90
43. Finegood DT McArthur MD Kojwang D Thomas MJ Topp BG Leonard T Buckingham RE β-Cell mass dynamics in Zucker diabetic fatty rats. Rosiglitazone prevents the rise in net cell death Diabetes 2001 50 1021 9
44. Funakoshi A Miyasaka K Jimi A Kawanai T Takata Y Kono A Little or no expression of the cholecystokinin-A receptor gene in the pancreas of diabetic rats (Otsuka Long-Evans Tokushima Fatty=OLETF rats) Biochem Biophys Res Commun 1994 199 482 8
45. Gerich JE Contributions of insulin-resistance and insulin-secretory defects to the pathogenesis of type 2 diabetes mellitus Mayo Clin Proc 2003 78 447 56
46. Gerstein HC Yusuf S Bosch J Pogue J Sheridan P Dinccag N Hanefeld M Hoogwerf B Laakso M Mohan V Shaw J Zinman B Holman RR Effect of rosiglitazone on the frequency of diabetes in patients with impaired glucose tolerance or impaired fasting glucose: a randomised controlled trial Lancet 2006 368 1096 105
47. Giroix MH Sener A Bailbe D Leclercq-Meyer V Portha B Malaisse WJ Metabolic, ionic and secretory response to D-glucose in islets from rats with acquired or inherited non-insulin-dependent diabetes Biochem Med Metab Biol 1993a 50 301 21
48. Giroix MH Vesco L Portha B Functional and metabolic perturbations in isolated pancreatic islets from the GK rat, a genetic model of noninsulin-dependent diabetes Endocrinology 1993b 132 815 22
49. Gottsater A Owens DR Luzio S Sundkvist G Proinsulin secretion during the first 3 years after diagnosis in diabetic patients with and without islet cell antibodies Diabetes Care 1996 19 659 62
50. Guenifi A Abdel-Halmi SM Hoog A Falkmer S Östenson CG Preserved beta-cell density in the endocrine pancreas of young, spontaneously diabetic Goto-Kakizaki (GK) rats Pancreas 1995 10 148 53
51. Guillam MT Hummler E Schaerer E Yeh JI Birnbaum MJ Beermann F Schmidt A Deriaz N Thorens B Early diabetes and abnormal postnatal pancreatic islet development in mice lacking Glut-2 Nat Genet 1997 17 249 50
52. Hansen BC The metabolic syndrome X Ann N Y Acad Sci 1999 892 1 24
53. Harding HP Zeng H Zhang Y Jungries R Chung P Plesken H Sabatini DD Ron D Diabetes mellitus and exocrine pancreatic dysfunction in perk -/- mice reveals a role for translational control in secretory cell survival Mol Cell 2001 7 1153 63
54. Harmon JS Gleason CE Tanaka Y Poitout V Robertson RP Antecedent hyperglycaemia, not hyperlipidaemia, is associated with increased triacylglycerol content and decreased insulin gene mRNA level in Zucker diabetic fatty rats Diabetes 2001 50 2481 6
55. Hirose H Lee YH Inman LR Nagasawa Y Johnson JH Unger RH Defective fatty acid-mediated β-cell compensation in Zucker diabetic fatty rats. Pathogenic implications for obesity-dependent diabetes J Biol Chem 1995 271 5633 7
56. Hoog A Hu W Abdel-Halim SM Falkmer S Qing L Grimelius L Ultrastructural localisation of insulin-like growth factor-2 (IGF-2) to the secretory granules of insulin cells: a study in normal and diabetic (GK) rats Ultrastruct Pathol 1997 21 457 66
57. Hoog A Sandberg-Nordqvist AC Abdel-Halim SM Carlsson-Skwirut C Guenifi A Tally M Östenson CG Falkmer S Sara VR Efendic S Schalling M Grimeluis L Increased amounts of a high molecular weight insulin-like growth factor (IGF-II) peptide and IGF-II messenger ribonucleic acid in pancreatic islets of Goto-Kakizaki rats Endocrinology 1996 137 2415 23
58. Homo-Delarche F Calderari S Irminder JC Gangnerau MN Coulaud J Rickenbach K Dolz M Halban P Portha B Islet inflammation and fibrosis in a spontaneous model of type 2 diabetes, the GK rat Diabetes 2006 55 1625 33
59. Höppener JWM Ahrén B Lip CJM Islet amyloid and type 2 diabetes mellitus N Engl J Med 2000 343 411 9
60. Hughes SJ Faehling M Thorneley CW Proks P Ashcroft FM Smith PA Electrophysiological and metabolic characterization of single beta-cells and islets from diabetic GK rats Diabetes 1998 47 73 81
61. Hughes SJ Suzuki K Goto Y The role of islet secretory function in the development of diabetes in the GK Wistar rat Diabetologia 1994 37 863 70
62. Hull RL Andrikopoulos S Verchere BC Vidal J Wang F Cnop M Prigeon RL Kahn S Increased dietary fat promotes islet amyloid formation and β-cell secretory dysfunction in a transgenic mouse model of islet amyloid Diabetes 2003 52 372 9
63. Hull RL Kodama K Utzschneider KM Carr DB Prigeon RL Kahn SE Dietary fat-induced obesity in mice results in beta cell hyperplasia but not increased insulin release: evidence for specificity of impaired beta cell adaptation Diabetologia 2005a 48 1350 8
64. Hull RL Watts MR Kodama K Shen ZP Utzschneider KM Carr DB Vidal J Kahn SE Genetic background determines the extent of islet amyloid formation in human islet amyloid polypeptide transgenic mice Am J Physiol Endocrinol Metab 2005b 289 E703 9
65. Isaksson B Wang F Permert J Olsson M Fruin B Herrington MK Enochsson L Erlanson-Albertsson C Arnelo U Chronically administered islet amyloid polypeptide in rats serves as an adiposity inhibitor and regulates energy homeostasis Pancreatology 2005 5 27 8
66. Janson J Soeller WC Roche PC Nelson RT Torchia AT Kreutter DK Butler PC Spontaneuos diabetes mellitus in transgenic mice expressing human islet amyloid polypeptide Proc Natl Acad Sci U S A 1996 93 7283 8
67. Janssen SWJ Hermus ARMM Lange WPH Knijnenburg Q van der Laak JAWM Sweep CGJ Martens GJM Verhofstad AAJ Progressive histopathological changes in pancreatic islets of Zucker diabetic fatty rats Exp Clin Endocrinol Diabetes 2001 109 273 82
68. Jhala US Canettieri G Screaton RA Kulkarni RN Krajewski S Reed J Walker J Lin Xueying L White M Montminy M cAMP promotes pancreatic β-cell survival via CREB-mediated induction of IRS2 Genes Dev 2003 17 1575 80
69. Jia D Taguchi M Otsuki M Synthetic protease inhibitor camostat prevents and reverses dyslipidemia, insulin secretory defects, and histological abnormalities of the pancreas in genetically obese and diabetic rats Metabolism 2005 54 619 27
70. Jia D Yamamoto M Otani M Otsuki M Bezafibrate on lipids and glucose metabolism in obese diabetic Otsuka Long-Evans Tokushima fatty rats Metabolism 2004 53 405 13
71. Johnson KH O’Brien TD Westermark P Newly identified pancreatic protein islet amyloid polypeptide. What is its relationship to diabetes? Diabetes 1991 40 310 4
72. Jonas JC Sharma A Hansenkamp W Ilkova H Patane G Laybutt R Bonner-Weir S Weir G Chronic hyperglycaemia triggers loss of pancreatic β cell differentiation in an animal model of diabetes J Biol Chem 1999 274 14112 21
73. Jones LC Clark A β Cell neogenesis in type 2 diabetes Diabetes 2001 50 S186 7
74. Kahn SE The relative contributions of insulin resistance and beta-cell dysfunction to the pathophysiology of type 2 diabetes Diabetologia 2003 46 3 19
75. Kaiser N Nesher R Donath M Fraenkel M Behar V Magnan C Ktorza A Cerasi E Leibowitz G Psammomys obesus, a model for environment-gene interactions in type 2 diabetes Diabetes 2005a 54 S137 44
76. Kaiser N Yuli M Üçkaya G Oprescu A Berthault MF Kargar C Donath M Erol C Ktorza A Dynamic changes in β-cell mass and pancreatic insulin during the evolution of nutrition-dependent diabetes in Psammomys obesus. Impact of glycemic control Diabetes 2005b 54 138 45
77. Katayama N Hughes SJ Persaud SJ Jones PM Howell SL Insulin secretion from islets of GK rats is not impaired after energy generating steps Mol Cell Endocrinol 1995 111 125 8
78. Kaufmann F Rodriguez RR Subtotal pancreatectomy in five different rat strains: incidence and course of development of diabetes Diabetologia 1984 27 38 43
79. Kawano K Hirashima T Mori S Saitoh Y Kurosumi M Natori T Spontaneous long-term hyperglycaemic rat with diabetic complications Otsuka Long-Evans Tokushima Fatty (OLETF) strain Diabetes 1992 41 1422 8
80. Klöppel G In’t Veld PA Alberti KGMM Zimmet P Defronzo RA Keen H Morphology of the pancreas in normal and diabetic states International Textbook of Diabetes Mellitus 1997 2 Chichester John Wiley & Sons Ltd 287 314
81. Ko SH Kwon HS Kim SR Moon SD Ahun YB Song KH Son HS Cha BY Lee KW Son HY Kang SK Park CG Lee IK Yoon KH Ramipril treatment suppresses islet fibrosis in Otsuka Long-Evans Tokushima fatty rats Biochem Biophys Res Commun 2004 316 114 22
82. Koyama M Wada R Sakuraba H Mizukami H Yagihashi S Accelerated loss of islet beta cells in sucrose-fed Goto Kakisaki rats, a genetic model of non-insulin dependent diabetes mellitus Am J Pathol 1998 153 537 45
83. Kubota N Terauchi Y Tobe K Yano W Suzuki R Ueki K Takamoto I Satoh H Maki T Kubota T Moroi M Okada-Iwabu M Ezaki O Nagai R Ueta Y Kadowaki T Noda T Insulin receptor substrate 2 plays a crucial role in beta cells and the hypothalamus J Clin Invest 2004 114 917 27
84. Kulkarni RN Brüning JC Winnay JN Postic C Magnuson MA Kahn R Tissue-specific knockout of the insulin receptor in pancreatic β cells creates an insulin secretory defect similar to that in type 2 diabetes Cell 1999 96 329 39
85. Kushner JA Ciemerych MA Sciniska E Wartschow LM Teta M Long SY Siciniski P White MF Cyclins D2 and D1 are essential for postnatal pancreatic β-cell growth Mol Cell Biol 2005 25 3752 62
86. Kushner JA Fawaz GH Klaman LD Dow MA Kahn BB Neel BG White MF Islet-sparing effects of protein tyrosine phosphatase-1b deficiency delays onset of diabetes in IRS2 knockout mice Diabetes 2004 53 61 6
87. Lampeter EF Tubes M Klemens C Brocker U Friemann J Kolb-Bachofen V Gries FA Kolb H Insulitis and islet-cell antibody formation in rats with experimentally reduced beta-cell mass Diabetologia 1995 38 1397 04
88. Langenfeld MR Forst T Standl E Strotmann HJ Lübben G Pahler S Kann P Pfützner A IRIS II study: sensitivity and specificity of intact proinsulin, adiponectin, and the proinsulin/adiponectin ratio as markers for insulin resistance Diabetes Technol Ther 2004 6 836 43
89. Laybutt DR Glandt M Xu G Ahn YB Trivedi N Bonner-Weir S Weir GC Critical reduction in beta-cell mass results in two distinct outcomes over time. Adaption with impaired glucose tolerance or decompensated diabetes J Biol Chem 2003 278 2997 3005
90. Laybutt DR Kaneto H Hasenkamp W Grey S Jonas JC Sgroi DC Groff A Ferren C Bonner-Weir S Sharma A Weir GC Increased expression of antioxidant and antiapoptotic genes in islets that may contribute to β-cell survival during chronic hyperglycaemia Diabetes 2002 51 413 23
91. Leahy JL Bonner-Weir S Weir GC Abnormal glucose regulation of insulin secretion of reduced B-cell mass Diabetes 1984 33 667 73
92. Lee Y Hirose H Zhou YT Esser V McGarry JD Unger RH Increased lipogenic capacity of the islets of obese rats: a role in the pathogenesis of NIDDM Diabetes 1997 46 408 13
93. Lee Y-H Sauer B Gonzalez J Laron dwarfism and non-insulin-dependent diabetes mellitus in the Hnf-1α knockout mouse Mol Cell Biol 1998 18 3059 68
94. Lei L Masaharu S Hidenori Y Kojima I Promotion of β-cell regeneration by β cellulin in ninety percent-pancreatectomized rats Endocrinology 2001 142 5379 85
95. Leibowitz G Yuli M Donath MY Nesher R Melloul D Cerasi E Gross DJ Kaiser N Beta-cell glucotoxicity in the Psammomys obesus model of type 2 diabetes Diabetes 2001 50 S113 17
96. Lewandowski PA Cameron-Smith D Jackson CJ Kultys ER Collier GR The role of lipogenesis in the development of obesity and diabetes in Israeli sand rats (Psammomys obesus) J Nutr 1998 128 1984 8
97. Lewis JT Foglia VG Rodriguez RR The effects of steroids on the incidence of diabetes in rats after subtotal pancreatectomy Endocrinology 1950 46 111 21
98. Lillioja S Bogardus C Obesity and insulin resistance: lessons learned from the Pima Indians Diabetes Metab Rev 1988 4 517 40
99. Lynn FC Pamir N Ng EHC McIntosh CHS Keiffer TJ Pederson RA Defective glucose-dependent insulinotrophic polypeptide receptor expression in diabetic fatty Zucker rats Diabetes 2001 50 1004 11
100. MacDonald MJ Efendic S Östenson CG Normalization by insulin treatment of low mitochondrial glycerol phosphate dehydrogenase and pyruvate carboxylase in pancreatic islets of the GK rat Diabetes 1996a 45 886 90
101. MacDonald MJ Tang J Polonsky KS Low mitochondrial glycerol phosphate carboxylase in pancreatic islets of Zucker diabetic fatty rats Diabetes 1996b 45 1326 30
102. Malaisse WJ Is type 2 diabetes due to a deficiency of FAD-linked glycerophosphate dehydrogenase in pancreatic islets? Acta Diabetol 1993 30 1 5
103. Mari A Gastaldelli A Natali A Ostergard T Schmitz O Ferrannini E Characterisation of β-cell function impairment in first-degree relatives of type 2 diabetic subjects: modelling analysis of 24h triple-meal tests Am J Physiol Endocrinol Metab 2005 288 E541 6
104. Martin JF Johnson CS Han C-T Benyshek DC Nutritional origins of insulin resistance: a rat model for diabetes-prone human populations J Nutr 2000 130 741 4
105. Matsuoka T Kajimoto Y Watada H Umayahara Y Kubota M Kawamori R Yamasaki Y Kamada T Expression of CD38 gene, but not of mitochondrial glycerol-3-phosphate dehydrogenase, is impaired in pancreatic islets of GK rats Biochem Biophys Res Commun 1995 214 239 46
106. Matveyenko A Butler P β-Cell deficit due to increased apoptosis in human islet amyloid polypeptide transgenic (HIP) rat recapitulates the metabolic defects present in type 2 diabetes Diabetes 2006 55 1206 14
107. Mauvis-Jarvis F Kahn RC Understanding the pathogenesis and treatment of insulin resistance and type 2 diabetes mellitus: what we learn from transgenic and knockout mice Diabetes Metab 2000 26 433 48
108. Milburn JL Hirose H Lee YH Nagasawa Y Ogawa A Makoto O Beltran del Rio H Newgard CB Johnson JH Unger RH Pancreatic β-cell obesity. Evidence for induction of functional morphologic, and metabolic abnormalities by increased long chain fatty acids J Biol Chem 1994 270 1295 9
109. Mine T Miura K Kitahara Y Okano A Kawamori R Nateglinide suppresses postprandial hypertension in Zucker fatty rats and Goto-Kakizaki rats: comparison with voglibose and glibenclamide Biol Pharmacol Bull 2002 25 1412 6
110. Miralles F Portha B Early development of β-cells is impaired in the GK rat model of type 2 diabetes Diabetes 2001 50 S84 8
111. Moller DE O’Rahilly S Moller DE Syndromes of severe insulin resistance: clinical and pathophysioloigical features Insulin Resistance 1993 New York John Wiley and Sons 49 82
112. Moran TH Bi S Hyperphagia and obesity of OLETF rats lacking CCK1 receptors: developmental aspects Dev Psychobiol 2006 48 360 7
113. Movassat J Saulnier C Portha B Beta-cell mass depletion precedes the onset of hyperglycaemia in the GK rats, a genetic model of non-insulin dependent diabetes mellitus Diabet Metab 1995 21 365 70
114. Movassat J Saulnier C Serradas P Portha B Impaired development of pancreatic beta-cell mass is a primary event during the progression to diabetes in the GK rat Diabetologia 1997 40 916 25
115. Murata M Takahashi A Saito I Kawanishi S Site-specific DNA methylation and apoptosis: induction by diabetogenic streptozotocin Biochem Pharmacol 1999 57 881 7
116. Nadi AB Malaisse WJ Altered metabolic priming by D-glucose in pancreatic islets from Goto-Kakizaki rats Int J Mol Med 2000 5 625 9
117. Ogilvie R The islands of Langerhans in 19 cases of obesity J Pathol 1933 38 478 81
118. Ohneda M Inman LR Unger RH Caloric restriction in obese pre-diabetic rats prevents beta-cell depletion, loss of beta-cell GLUT 2 and glucose incompetence Diabetologia 1995 38 173 9
119. Ohneda M Johnson JH Inman LR Chen L Suzuki K Goto Y Alam T Ravazzola M Ocri L Unger RH GLUT2 expression and function in the beta-cells of GK rats with NIDDM. Dissociation between reductions in glucose transport and glucose-stimulated insulin secretion Diabetes 1993 42 1065 72
120. Okamoto Y Ishida H Tsuura Y Yasuda K Kato S Matsubara H Nishimura M Mizuno N Ikeda H Seino Y Hyperresponse in calcium-induced insulin release from electrically permeabilized pancreatic islets of diabetic GK rats and its defective augmentation by glucose Diabetologia 1995 38 772 8
121. Opie EL The relationship of diabetes mellitus to lesions of the pancreas. Hyaline degeneration of the islands of Langerhans J Exp Med 1900 5 397 428
122. Orland MJ Chyn R Permutt MA Modulation of proinsulin messenger RNA after partial pancreatectomy in rats. Relationships to glucose homeostasis J Clin Invest 1985 75 2047 55
123. O’Rourke CM Davis JA Saltiel AR Cornicelli JA Metabolic effects of troglitazone in the Goto-Kakizaki rat, a non-obese and normolipidemic rodent model of non-insulin dependent diabetes mellitus Metabolism 1997 46 192 8
124. Östenson CG Sima AAF Shafrir E The Goto-Kakizaki rat Animal Models of Diabetes, A primer 2001 Harwood Academic Publishers 197 212
125. Östenson CG Khan A Abdel-Halim SM Guenifi A Suzuki K Goto Y Efendic S Abnormal insulin secretion and glucose metabolism in pancreatic islets from the spontaneously diabetic GK rat Diabetologia 1993 36 3 8
126. Otani K Kulkarni RN Baldwin AC Krutzfeldt J Ueki K Stoffel M Kahn CR Polonsky KS Reduced beta-cell mass and altered glucose sensing impair insulin-secretory function in beta IR ko mice Am J Physiol Endocrinol Metab 2004 286 E41 9
127. Otieno CF Kayima JK Omonge EO Oyoo GO Diabetic ketoacidosis: risk factors, mechanisms and management strategies in sub-Saharan Africa: a review East Afr Med J 2005 82 S197 203
128. Pang K Mukonoweshuro C Wong GG Beta cells arise from glucose transporter type 2 (glut2)-expressing epithelial cells of the developing pancreas Proc Natl Acad Sci U S A 1994 91 9559 63
129. Pascoe WS Storlien LH Inducement by fat feeding of basal hyperglycaemia in rats with abnormal beta-cell function. Model for studies of etiology and pathogenesis of NIDDM Diabetes 1990 39 226 33
130. Peiper AA Brat DJ Krug DK Watkins CC Gupta A Blackshaw S Verma A Wang ZQ Snyder SH Poly(ADP-ribose) polymerase-deficient mice are protected from streptozotocin-induced diabetes Proc Natl Acad Sci U S A 1999 96 3059 62
131. Perry IJ Wannamethee SG Walker MK Thomson AG Whincup PH Shaper AG Prospective study of risk factors for development of non-insulin dependent diabetes in middle aged British men BMJ 1995 310 560 64
132. Peterson RG Shaw WN Neel M-A Little LA Eichberg J Zucker diabetic fatty rat as a model for non-insulin dependent diabetes mellitus ILAR J 1990 32 16 9
133. Pfützner A Pfützner AH Larbig M Forst T Role of intact proinsulin in diagnosis and treatment of type 2 diabetes mellitus Diabetes Technol Ther 2004 6 405 12
134. Pickavance LC Widdowson PS Foster JR Williams G Wilding JPH Chronic treatment with the thiazolidinedione, MC-555, is associated with reductions in nitric oxide synthase activity and β-cell apoptosis in the pancreas of the Zucker diabetic fatty rat Int J Exper Pathol 2003 84 83 9
135. Portha B Giroix MH Serradas P Gangnerau MN Movassat J Rajas F Bailbe D Plachot C Mithieux G Marie JC Beta-cell function and viability in the spontaneously diabetic GK rat: information from the GK/Par colony Diabetes 2001 50 S89 93
136. Randle PJ Regulatory interactions between lipids and carbohydrates: the glucose fatty acid cycle after 35 years Diabetes Metab Rev 1998 14 263 83
137. Reaven GM Pathophysiology of insulin resistance in human disease Physiol Rev 1995 75 473 86
138. Reed MJ Meszaros K Entes LJ Claypool MD Pinkett JG Gadbois TM Reaven GM A new rat model of type 2 diabetes: the fat-fed, streptozotocin-treated rat Metabolism 2000 49 1390 4
139. Rees DA Alcolado JC Animal models of diabetes mellitus Diabetic Med 2005 22 359 70
140. Remedi MS Koster JC Patton BL Nichols CG ATP-sensitive K+ channel signalling in glucokinase-deficient diabetes Diabetes 2005 54 2925 31
141. Rossetti L Shulman GI Zawalich W DeFronzo RA Effect of chronic hyperglycaemia on in vivo insulin secretion in partially pacre-atectomized rats J Clin Invest 1987 80 1037 44
142. Sawant SP Dnyanmote AV Shankar K Limaye PB Latendresse JR Mehendale HM Potentiation of carbon tetrachloride hepatotoxicity and lethality in type 2 diabetic rats J Pharmacol Exp Ther 2004 308 694 703
143. Schnedl WJ Ferber S Johnson JH Newgard CB STZ transport and cytotoxicity. Specific enhancement in GLUT2-expressing cells Diabetes 1994 43 1326 33
144. Shimabukuro M Ohneda M Lee Y Unger R Role of nitric oxide in obesity-induced β cell disease J Clin Invest 1997 100 290 295
145. Shimabukuro M Zhou YT Moshe L Unger RH Fatty acid-induced β cell apoptosis: a link between obesity and diabetes Proc Natl Acad Sci U S A 1998 95 2498 502
146. Shimoshige Y Ikuma K Yamamoto T Takakura S Kawamura I Jiro S Mutoh S Goto T The effects of zenarestat, an aldose reductase inhibitor, on peripheral neuropathies in Zucker diabetic fatty rats Metabolism 2000 49 1395 9
147. Sieca RM Martins MJ Pessa PB Santos RM Rosario LM Suzuki KI Martins MI Morphological changes of islet of Langerhans in an animal model of type 2 diabetes Acta Med Port 2003 16 381 8
148. Smith SA Lister CA Toseland CD Buckingham RE Rosiglitazone prevents the onset of hyperglycaemia and proteinuria in the Zucker diabetic fatty rat Diabetes Obes Metab 2000 2 363 72
149. Soeller WC Janson J Emeight S Parker JC Carty MD Stevenson RW Kreutter DK Butler PC Islet amyloid-associated diabetes in obese Avy/a mice expressing human islet amyloid polypeptide Diabetes 1998 47 743 50
150. Srinivasan K Viswanad B Asrat L Kaul CL Ramarao P Combination of high-fat diet-fed and low-dose streptozotocin-treated rat: a model for type 2 diabetes and pharmacological screening Pharm Res 2005 52 313 20
151. Srinivasan M Laychock SG Hill DJ Patel MS Neonatal nutrition: metabolic programming of pancreatic islets and obesity Exp Biol Med 2003 228 15 23
152. Sturis J Pugh WL Tang J Ostrega DM Polonsky JS Polonsky KS Alterations in pulsatile insulin secretion in the Zucker diabetic fatty rat Am J Physiol 1994 267 E250 9
153. Sudre B Broqua P White RB Ashworth D Evans DM Haigh R Junien JL Aubert ML Chronic inhibition of circulating dipeptidyl peptidase IV by FE 999011 delays the occurrence of diabetes in male Zucker diabetic fatty rats Diabetes 2002 51 1461 9
154. Suzuki N Aizawa T Asanuma N Sato Y Komatsu M Hidaka H Itoh N Yamauchi K Hashizume K An early insulin intervention accelerates pancreatic β-cell dysfunction in young Goto-Kakizaki rats, a model of naturally occurring noninsulin-dependent diabetes Endocrinology 1997 138 1106 10
155. Svensson AM Abdel-Halim SM Efendic S Jansson L Östenson CG Pancreatic and islet blood flow in F1-hybrids of the non-insulin dependent diabetic GK-Wistar rat Eur J Endocrinol 1994 130 612 6
156. Svensson AM Östenson CG Jansson L Age-induced changes in pancreatic islet blood flow: evidence for an impaired regulation in diabetic GK rats Am J Physiol Endocrinol Metab 2000 279 E1139 44
157. Tachibana I Akiyama T Kanagawa K Shirohara H Furumi K Watanabe N Otsuki M Defect in pancreatic exocrine and endocrine response to CCK in genetically diabetic OLETF rats Am J Physiol Gastrointest Liver Physiol 1996 270 G730 7
158. Terauchi Y Sakura H Yasuda K Iwamoto K Takahashi N Ito K Kasai H Suzuki H Ueda O Kamada N Jishage K Komeda K Noda M Kanazawa Y Taniguchi S Miwa I Akanuma Y Kodama T Yazaki Y Kadowaki T Pancreatic β-cell-specific targeted disruption of glucokinase gene J Biol Chem 1995 270 30253 6
159. Tikellis C Wookey PJ Candido R Andrikopoulos S Thomas MC Cooper ME Improved islet morphology after the blockade of the renin-angiotensin system in the ZDF rat Diabetes 2004 53 989 97
160. Tokuyama Y Sturis J DePaoli AM Takeda J Stoffel M Tang J Sun X Polonsky KS Bell GI Evolution of beta-cell dysfunction in the male Zucker diabetic fatty rat Diabetes 1995 44 1447 57
161. Tsuura Y Ishida H Okamoto Y Kato S Horie M Ikeda H Seino Y Reduced sensitivity of dihydroxyacetone on ATP-sensitive K+ channels of pancreatic beta cells in GK rats Diabetologia 1994 37 1082 7
162. Turk J Corbett JA Ramanadham S Bohrer A McDaniel ML Biochemical evidence for nitric oxide formation from streptozotocin in isolated pancreatic islets Biochem Biophys Res Commun 1993 197 1458 64
163. Uchigata Y Yamamoto H Kawamura A Okamoto H Protection by superoxide dismutase, catalase, and poly(ADP-ribose) synthetase inhibitors against alloxan- and streptozotocin-induced islet DNA strand breaks and against the inhibition of proinsulin synthesis J Biol Chem 1982 257 6084 8
164. Üçkaya G Delagrange P Chavanieu A Grassy G Berthault M-F Ktorza A Cerassi E Leibowitz G Kaiser N Improvement of metabolic state in an animal model of nutrition-dependent type 2 diabetes following treatment with S23521, a new glucagon-like peptide 1 (GLP1) analogue J Endocrinol 2005 184 505 13
165. Ueda K Tanizawa Y Ishihara H Kizuki N Ohta Y Matsutani A Oka Y Overexpression of mitochondrial FAD-linked glycerol-3-phosphate dehydrogenase does not correct glucose-stimulated insulin secretion from diabetic GK rat pancreatic islets Diabetologia 1998 41 649 53
166. Unger R How obesity causes diabetes in Zucker diabetic fatty rats Trends Endocrinol Metabol 1997 8 276 82
167. Vadlamudi S Hiremagalur BK Tao L Kalhan SC Kalaria RN Kaung HL Patel MS Long-term effects on pancreatic function of feeding a HC formula to rats during the preweaning period Am J Physiol 1993 265 E565 71
168. Vauhkonen I Niskanen L Vanninen E Kainulainen S Uusitupa M Laasko M Defects in insulin secretion and insulin action in non-insulin-dependent diabetes mellitus are inherited J Clin Invest 1998 101 86 96
169. Vickers MH Breier BH Cutfield WS Hofman PL Gluckman PD Fetal origins of hyperglycaemia, obesity and hypertension and postnatal amplification by hypercaloric nutrition Am J Physiol Endocrinol Metab 2000 279 E83 7
170. Vickers MH Gluckman PD Coveny AH Hofman PL Cutfield WS Gertler A Breier BH Harris M Neonatal leptin treatment reverses developmental programming Endocrinology 2005 146 4211 6
171. Vickers MH Reddy S Ikenasio BA Breier BH Dysregulation of the adipoinsular axis—a mechanism for the pathogenesis of hyperleptinaemia and adipogenic diabetes induced by fetal programming J Endocrinol 2001 170 323 32
172. Wada R Yagihashi S Nitric oxide generation and poly(ADP ribose) polymerase activation precede beta-cell death in rats with a single high-dose injection of streptozotocin Virchows Arch 2004 444 375 82
173. Wang F Westermark G Gasslander T Permert J Effect of islet amyloid polypeptide on somatostatin inhibition of insulin secretion from isolated rat pancreatic islets Regul Pept 1997 72 61 7
174. Wang MY Koyama K Shimabukuro M Manelsdorf D Newgard CB Unger RH Overexpression of leptin receptors in pancreatic islets of Zucker diabetic fatty rats restores GLUT-2, glucokinase, and glucose-stimulated insulin secretion Proc Natl Acad Sci U S A 1998 95 11921 6
175. Wargent E Stocker C Augstein P Heinke P Meyer A Hoffmann T Subramanian A Sennitt MV Demouth H-U Arch JRS Cawthorne MA Improvement of glucose tolerance in Zucker diabetic fatty rats by long term treatment with the dipeptidyl peptidase inhibitor P32/98: comparison with and combination with Rosiglitazone Diabetes, Obesity and Metabol 2005 7 170 81
176. Wasan KM Risovic V Yuen VG McNeill JH Differences in plasma homocysteine levels between Zucker fatty and Zucker diabetic fatty rats following 3 weeks oral administration of organic vanadium compounds J Trace Elem Med Biol 2006 19 251 8
177. Weng X Liu Y Ma J Wang W Yang G Caballero B Use of body mass index to identify obesity-related metabolic disorders in the Chinese population Eur J Clin Nutr 2006 60 931 7
178. Westermark P Engstrom E Johnson KH Westermark GT Betsholtz C Islet amyloid polypeptide: pinpointing amino acid residues linked to amyloid fibril formation Proc Natl Acad Sci U S A 1990 87 5036 40
179. Westermark P Wilander E Westermark GT Johnson KH Islet amyloid polypeptide-like immunoreactivity in the islet B cells of type 2 (non-insulin dependent) diabetic and non-diabetic individuals Diabetologia 1997 30 887 92
180. Wierup N Svensson H Mulder H Sundler F The ghrelin cell: a novel developmentally regulated islet cell in the human pancreas Regul Pept 2002 107 63 9
181. Wilson GL Hartig PC Patton NJ LeDoux SP Mechanisms of nitrosourea-induced beta-cell damage. Activation of poly(ADP-ribose) synthetase and cellular distribution Diabetes 1988 3 213 6
182. Withers DJ Gutierrez JS Towery H Burks DJ Ren J-M Previs S Zhang Y Bernal D Pons S Shulman G Bonner-Weir S White MF Disruption of IRS-2 causes type 2 diabetes in mice Nature 1998 391 900 4
183. Yagi K Kim S Wanibuchi H Yamashita T Yamamura Y Iwao H Characteristics of diabetes, blood pressure and cardiac complications in Otuska Long-Evans Tokushima Fatty rats Hypertension 1997 29 728 35
184. Yano BL Johnson KH Hayden DW Feline insular amyloid: histochemical distinction from secondary systemic amyloid Vet Pathol 1981 18 181 7
185. Yomemura Y Takashima T Matsuki N Hagino S Sawa T Takashima S Miwa K Miyazaki I The pathogenesis of diabetes produced by subtotal pancreatectomy, with special reference to the cell kinetics of the islet cells Nippon Geka Gakkai Zasshi 1984 85 356 62
186. Zaitsev S Efanova I Östenson CG Efendic S Berggren PO Delayed Ca2+ response to glucose in diabetic GK rat Biochem Biophys Res Commun 1997 239 129 33
187. Zhang F Ye C Li G Ding W Zhou W Zhu H Chen G Luo T Guang M Liu Y Zhang D Zheng S Yang J Gu Y Xie X Luo M The rat model of type 2 diabetic mellitus and its glycometabolism characters Exp Anim 2003 52 401 7
188. Zhao HL Lai FMM Tong PCY Zhong DR Yang D Tomlinson B Chan JCN Prevalence and clinicopathological characteristics of islet amyloid in Chinese patients with type 2 diabetes Diabetes 2003 52 2759 66
189. Zhou YP Östenson CG Ling ZC Grill V Deficiency of pyruvate dehydrogenase activity in pancreatic islets of diabetic GK rats Endocrinology 1995 136 3546 51
190. Ziegler M Ziegler B Hehmke B Severe hyperglycaemia caused by autoimmunization to β cells in rats Diabetologia 1984 27 163 65
191. Zimmet P Alberti KGMM Shaw J Global and societal implications of the diabetes epidemic Nature 2001 414 782 7
192. Ziv E Kalman R Hershkop K Barasg V Shafrir E Bar-On H Insulin resistance in the NIDDM model Psammomys obesus in the normoglycaemia, normoinsulinaemic state Diabetologia 1996 39 1269 75